WHO South-East Asia Journal of Public Health

REPORT FROM THE FIELD
Year
: 2013  |  Volume : 2  |  Issue : 2  |  Page : 118--120

National policies for safety of medicines in the Asia Pacific region


Socorro Escalante1, John McEwen2 
1 Technical Officer and Medicines Policy Adviser, WHO Country Office for Viet Nam, Canberra, Australia
2 Discipline of Pharmacy, University of Canberra, Australia

Correspondence Address:
John McEwen
Discipline of Pharmacy, University of Canberra, Bruce, Australian Capital Territory, 2617
Australia

National medicines policies can aid the safe use of medicines by ensuring availability of quality products, appropriate information for prescribers and consumers, strengthening the national medicines regulatory capacity and improving access to expert advice and authoritative laboratory testing. We report the findings of a workshop on medicines safety, which focused on the Asia Pacific region. Participants noted that external support is needed for resource-poor countries and that national medicines policies should include surveillance on problems with medicines, rather than the more limited monitoring of adverse drug reactions. The latter approach may be the only sensible option in countries in the Asia Pacific with very small populations.


How to cite this article:
Escalante S, McEwen J. National policies for safety of medicines in the Asia Pacific region.WHO South-East Asia J Public Health 2013;2:118-120


How to cite this URL:
Escalante S, McEwen J. National policies for safety of medicines in the Asia Pacific region. WHO South-East Asia J Public Health [serial online] 2013 [cited 2021 Mar 9 ];2:118-120
Available from: http://www.who-seajph.org/article.asp?issn=2224-3151;year=2013;volume=2;issue=2;spage=118;epage=120;aulast=Escalante;type=0